“…Growing evidence demonstrates that the p38MAPK family plays an important role in intracellular signal transduction in response to extracellular stimuli, including intestinal I/R challenge (Fu, Xing, et al, 2003;Fu, Yang, et al, 2003;Guo et al, 2016;Li et al, 2021;Li, Xu, et al, 2017;Liu et al, 2020;Ming et al, 2019;Murayama et al, 2006;Santén et al, 2009;Yusof et al, 2009;Zheng et al, 2005). Dexmedetomidine (Liu et al, 2020), propofol (Li et al, 2021), and 6-gingerol (Li, Xu, et al, 2017) have been shown to protect against intestinal I/R injury via p38MAPK inhibition, wherein p38MAPK activation conferred detrimental effects on intestinal I/R progression.…”